RxDoctor Payments Data

Courteney Gooch, PA

Surgical · Little Rock, ARNPI 1366921280

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Abiomed at 36.2% of the total. Reporting peaked in 2023 at $293 and has fallen 61.1% since, to $114 in 2025.

$974in general payments, 2019–2025

Across 24 payments — averaging $40.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abiomed$353
  • Abbott$159
  • AbbVie$127
  • Janssen Scientific Affairs, LLC$94
  • Pfizer$93
  • Amgen$87
  • plus $62 from 2 others
$148in research payments, 2019–2025

Across 1 payment — averaging $148.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abiomed$148

What the payments were for

  • Food & beverage$974100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$974 in reported general payments places this provider in the 80th percentile of 30 surgical providers in Arkansas.

See all surgical providers in Arkansas

Medicare billing

Part B allowed, 2024
$29,344
Medicare patients
130
Services billed
345

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban75$45,998
XareltoRivaroxaban77$44,432
EntrestoSacubitril/Valsartan43$27,795
BrilintaTicagrelor25$12,710
FarxigaDapagliflozin Propanediol21$11,833
ClopidogrelClopidogrel Bisulfate180$2,042
Atorvastatin Calcium86$1,161
Bumetanide21$645
Potassium Chloride25$543
Metoprolol Succinate44$446
Amiodarone Hcl41$367
Spironolactone33$279
Midodrine Hcl12$277
Isosorbide Mononitrate ErIsosorbide Mononitrate14$252
Ranolazine ErRanolazine12$229

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$93$45,99875 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 30 surgical providers in Arkansas.

Other surgical in Little Rock

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →